MedicaidPrior AuthMedium impact
Jevtana® (cabazitaxel) (Revised)
Humana·OH · Oncology·Medicaid
We identified it
Jul 21, 2026
Summary
This is a revised Prior Authorization policy for Jevtana® (cabazitaxel) affecting Medicaid members in Ohio. The policy update requires billing and clinical staff to review current authorization requirements and procedures for this chemotherapy agent to ensure compliance with the new guidelines.
Action Required
Immediately: Obtain and review the complete Jevtana® (cabazitaxel) Prior Authorization policy from Humana Ohio Medicaid at the provided source URL. Billing team must: (1) Verify current prior authorization procedures in billing system for HCPCS code J9043; (2) Confirm all required clinical documentation and medical necessity criteria with the revised policy; (3) Update any internal protocols or templates that reference prior authorization requirements for this drug; (4) Alert oncology providers that prior authorization requirements may have changed; (5) Test billing workflows to ensure claims are submitted with proper prior authorization. Failure to follow updated prior authorization procedures will result in claim denials for Medicaid Ohio members.